Quantum Genomics S.A. - ROE
QNNTF
Price:
$0.1
Market Cap:
$5.00M
Quantum Genomics S.A., a biopharmaceutical enterprise headquartered in Paris, France, was established in 2005. The company specializes in advancing therapeutic solutions for cardiovascular ailments. Its drug development efforts are anchored in the brain aminopeptidase A inhibition (BAPAI) platform, primarily targeting hypertension (high blood pressure) and heart failure. Among its pipeline, firibastat is a notable candidate, currently undergoing a crucial Phase III study as a standalone treatment for high blood pressure, and is also progressing through clinical trials for heart failure. Furthermore, Quantum Genomics is developing QGC011 for combination therapy in hypertension, alongside QGC0...[Read more]
Industry
Biotechnology
IPO Date
2021-05-19
Stock Exchange
OTC
Ticker
QNNTF
PE Ratio
[-0.11]
ROE
[880.77%]
Current Ratio
[2.05]
Dividend Yield
[0%]
Enterprise Value
[7.34M]
Dividend History
The ROE as of June 2026 (TTM) for Quantum Genomics S.A. (QNNTF) is 880.77%
According to Quantum Genomics S.A.’s latest financial reports and current stock price. The company's current ROE is 880.77%. This represents a change of 3.58% compared to the average of 23.91% of the last 4 quarters.
Quantum Genomics S.A. (QNNTF) Historical ROE (quarterly & annually)
How has QNNTF ROE performed in the past?
The mean historical ROE of Quantum Genomics S.A. over the last ten years is -170.07%. The current 880.77% ROE has changed -617.89% with respect to the historical average. Over the past ten years (40 quarters), QNNTF's ROE was at its highest in in the December 2014 quarter at 715.91%. The ROE was at its lowest in in the December 2022 quarter at -445.94%.
Average
-170.07%
Median
-98.77%
Minimum
-726.18%
Maximum
362.09%
Quantum Genomics S.A. (QNNTF) ROE by Quarter and Year
Discovering the peaks and valleys of Quantum Genomics S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 284.92%
Maximum Annual ROE = 362.09%
Minimum Annual Increase = -149.86%
Minimum Annual ROE = -726.18%
| Year | ROE | Change |
|---|---|---|
| 2024 | 362.09% | -149.86% |
| 2023 | -726.18% | 5.06% |
| 2022 | -691.19% | 284.92% |
| 2021 | -179.57% | 172.87% |
| 2020 | -65.81% | -31.82% |
| 2019 | -96.52% | -4.47% |
| 2018 | -101.03% | -4.46% |
| 2017 | -105.75% | 112.34% |
| 2016 | -49.80% | 6.13% |
| 2015 | -46.92% | -102.76% |
Quantum Genomics S.A. (QNNTF) Average ROE
How has QNNTF ROE performed in the past?
The current ROE of Quantum Genomics S.A. (QNNTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-351.76%
5-year avg
-260.13%
10-year avg
-170.07%
Quantum Genomics S.A. (QNNTF) ROE vs. Peers
How is QNNTF’s ROE compared to its peers?
Quantum Genomics S.A.’s ROE is less than Chimeric Therapeutics Limited (2.84%), less than Theralink Technologies, Inc. (147.47%), less than Curative Biotechnology, Inc. (41.35%), less than LianBio (11.78%), less than BetterLife Pharma Inc. (15.84%), greater than PharmaTher Holdings Ltd. (-155.46%), greater than Tristar Wellness Solutions Inc. (0.25%), greater than ProText Mobility, Inc. (0%), greater than NanoSphere Health Sciences Inc. (6.14%), greater than Glow Lifetech Corp. (-20.26%),
| Company | ROE | Market cap |
|---|---|---|
| 2.84% | $4.10M | |
| 147.47% | $615.15K | |
| 41.35% | $8.96M | |
| 11.78% | $12.11M | |
| 15.84% | $7.77M | |
| -155.46% | $4.00M | |
| 0.25% | $42.00K | |
| 0% | $10.71M | |
| 6.14% | $98.64K | |
| -20.26% | $6.13M |
Build a custom stock screener for Quantum Genomics S.A. (QNNTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quantum Genomics S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Quantum Genomics S.A. (QNNTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Quantum Genomics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Quantum Genomics S.A.'s ROE?
How is the ROE calculated for Quantum Genomics S.A. (QNNTF)?
What is the highest ROE for Quantum Genomics S.A. (QNNTF)?
What is the 3-year average ROE for Quantum Genomics S.A. (QNNTF)?
What is the 5-year average ROE for Quantum Genomics S.A. (QNNTF)?
How does the current ROE for Quantum Genomics S.A. (QNNTF) compare to its historical average?